Hansen MedicalĀ® Reports Latest Publication in the Journal of Interventional Cardiac Electrophysiology

Life Science Investing News

Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the latest publication in the Journal of Cardiac Electrophysiology: Analysis of catheter contact force during atrial fibrillation ablation, using the robotic navigation system: results from a randomized study.

Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the latest publication in the Journal of Cardiac Electrophysiology: Analysis of catheter contact force during atrial fibrillation ablation, using the robotic navigation system: results from a randomized study.
According to the company press release:

The purpose of this study, led by Dr. Antonio Dello Russo and Dr. Claudio Tondo of the Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino in Milan, Italy, was to evaluate catheter contact force (CF) measurements both with and without the use of SenseiĀ® X robotic navigation system (RNS) during pulmonary vein isolation (PVI) procedures. The study evaluated eighty patients with symptomatic atrial fibrillation (AF). Fifty-seven patients had paroxysmal AF and 23 early persistent AF. All procedures were performed with the ThermocoolĀ® SmartTouchā„¢ ablation catheter.

Dr. Joe Gallinghouse, M.D., Cardiac Electrophysiologist commented:

There is a substantial amount of innovation in the treatment of atrial fibrillation for catheter ablation, including distal tip contact force sensing catheters like SmartTouch. Early studies have indicated that the combination of SmartTouch and Sensei robotic navigation could provide improved outcomes for patients.

Click here to view the full press release.
Ā 

The Conversation (0)
Ɨ